CCBR Clinical Research Report issue

For profit Phase 2 Phase 3
Founded: Newark CA United States (1998)
Status: Acquired by BioClinica, Inc. (2014)

Organization Overview

First Clinical Trial
2011
NCT01321723
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CCBR | CCBR, Aalborg | CCBR Aalborg A/S, Aalborg, Denmark | CCBR SP

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dizziness (Phase 3)

Headache (Phase 3)

Migraine Disorders (Phase 3)

Osteoarthritis, Knee (Phase 2)

Osteoporosis (Phase 2)

Osteoporosis, Postmenopausal (Phase 2)

Vertigo (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 7